T1	Participants 111 143	treatment of Helicobacter pylori
T2	Participants 483 516	patients with H. pylori infection
T3	Participants 518 634	Sixty patients with peptic ulcer (gastric, 32 patients; duodenal, 28 patients) who had a history of ulcer recurrence
T4	Participants 925 1082	Forty-eight patients completed the protocol; treatment was discontinued because of side effects in nine patients, and three patients dropped out of the study
